High throughput screening of mutagenized populations

Patent metadata

Field	Value
Publication number	US-9376719-B2
Application number	US-201313972152-A
Country	US
Kind code	B2
Filing date	Aug 21, 2013
Priority date	Sep 29, 2005
Publication date	Jun 28, 2016
Grant date	Jun 28, 2016

Abstract

Efficient methods are disclosed for the high throughput identification of mutations in genes in members of mutagenized populations. The methods comprise DNA isolation, pooling, amplification, creation of libraries, high throughput sequencing of libraries, preferably by sequencing-by-synthesis technologies, identification of mutations and identification of the member of the population carrying the mutation and identification of the mutation.

First claim

The invention claimed is:

1. A method for the detection of a mutation in a target sequence in one or more members of a mutagenized population, comprising:
(a) providing a plurality of pools of amplification products each comprising the target sequence amplified from genomic DNA of a subset of the one or more members of the mutagenized population, wherein each pool of the amplification products shares a unique pool identifier;
(b) determining the nucleotide sequence of the amplification products using high throughput sequencing; and
(c) identifying mutations by clustering/aligning the sequences of the amplified products without the use of an enzyme which recognizes and cuts single nucleotide sequence mismatches and without performing heteroduplex analysis, and identifying the one or more members carrying the mutation using the pool identifier.

2. The method according to claim 1 , wherein the mutagenized population is obtained by treating the genome with one or more selected from the group consisting of mutation-inducing chemicals, ionizing radiation, targeted nucleotide exchange or region targeted mutagenesis.

3. The method according to claim 1 , wherein the mutagenized population comprises sub-populations that contain naturally occurring mutations.

4. The method according to claim 1 , wherein the amplification products are pooled using a 3D-pooling strategy.

5. The method according to claim 1 , wherein the high throughput sequencing is performed by Sequencing-by-Synthesis.

6. The method according to claim 1 , wherein the high throughput sequencing is performed by pyrosequencing.

7. The method according to claim 1 , wherein sequencing is performed on a solid support.

8. The method according to claim 7 , wherein the solid support is a bead.

9. The method according to claim 7 , wherein sequencing comprises: (i) ligating sequencing adaptors to the amplification products; (ii) annealing the adaptor-ligated products to beads, each bead annealing with a single product; (iii) emulsifying the beads in water-in-oil microreactors such that each microreactor contains a single bead; (iv) performing emulsion PCR to amplify adaptor-ligated products on the surface of the beads; (v) selecting/enriching beads to which are attached the amplified adaptor-ligated products; (vi) placing the beads in wells such that each well comprises a single bead; and generating a pyrophosphate signal.

10. The method according to claim 1 , wherein the primers contain nucleotides with improved binding affinity.

11. The method according to claim 1 , wherein the target sequence that is amplified is from about 80 to about 400 bp.

12. The method according to claim 1 , wherein the target sequence that is amplified is from about 90 to about 300 bp.

13. The method according to claim 1 , wherein the target sequence that is amplified is from 100 to about 200 bp.

14. The method according to claim 1 , wherein the method further comprises fragmenting the amplification products.

15. The method according to claim 1 , wherein the method further comprises confirming the mutation by amplifying the target sequence from the identified products of (c) using the primers of step (a) and determining the sequence of the amplified product.

16. The method according to claim 1 , wherein at least one of the primers comprises a gene-specific section, a tag and a sequence primer binding site.

17. The method according to claim 1 , wherein the amplified products are sequenced with an average redundancy of at least 4.

18. The method according to claim 1 , wherein the amplified products are sequenced with an average redundancy of at least 10.

19. The method according to claim 1 , wherein the amplified products are sequenced with an average redundancy of at least 25.

20. The method according to claim 19 , wherein the amplified products are sequenced with an average redundancy of at least 50.

Assignees

• Keygene Nv

Inventors

• Eijk Michael Josephus Theresia Van
• Tunen Adrianus Johannes Van

Classifications

• C12Q1/6855

  Ligating adaptors · CPC title

• C12Q1/6869

  Methods for sequencing · CPC title

• C12Q1/6851

  Quantitative amplification · CPC title

• C12Q1/6827

  for detection of mutation or polymorphism · CPC title

• C12Q2600/13

  Plant traits · CPC title